Toxoplasma gondii IgG Control Serum BC110G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Toxoplasma gondii IgG Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC110G Categories: control serum, Virion/Serion kits Tags: ELISA control serum, IgG, Toxoplasma gondii

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Toxoplasma gondii reactive IgG
species reactivity	Toxoplasma gondii
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Toxoplasma gondii IgG Control Serum BC110G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Toxoplasma gondii Avidity Reagent (B110AVID) Toxoplasma gondii Antigen (BA110VS) Toxoplasma gondii IgG Control Serum (BC110G) Toxoplasma gondii IgM Control Serum (BC110M) Toxoplasma gondii IgG ELISA Kit (ESR110G) Toxoplasma gondii IgM ELISA Kit (ESR110M)

target relevance

human antibody anti-Toxoplasma gondii

Toxoplasma gondii

Description
Protozoan parasite that causes toxoplasmosis

Structure
Toxoplasma gondii is an obligate intracellular protozoan parasite belonging to the phylum Apicomplexa. The parasite has a complex life cycle involving both sexual and asexual stages. Members of the cat family (Felidae) serve as the definitive hosts in which sexual reproduction occurs, while a wide range of warm-blooded animals, including humans, act as intermediate hosts. T. gondii exists in several developmental forms, including rapidly dividing tachyzoites, slowly replicating tissue cysts containing bradyzoites, and environmentally resistant oocysts shed in feline feces. The parasite is distributed worldwide and is one of the most common parasitic infections of humans. Following infection, T. gondii can establish lifelong latent infection within muscle and neural tissues through the formation of tissue cysts.

Diagnosis
The diagnosis of Toxoplasma gondii infection is performed through serological, molecular, histological, and microbiological methods. Serological testing is the most commonly used diagnostic approach and includes detection of Toxoplasma-specific IgM and IgG antibodies using ELISA and other immunoassays. Measurement of antibody avidity may help distinguish recent from past infection. Molecular techniques such as polymerase chain reaction (PCR) are widely used for detecting parasite DNA in blood, cerebrospinal fluid, amniotic fluid, and tissue specimens, particularly in congenital infections and immunocompromised patients. Histopathological examination and direct visualization of parasites may also aid diagnosis in selected cases. Early diagnosis is especially important during pregnancy because of the risk of congenital transmission.

Symptoms
Most immunocompetent individuals infected with Toxoplasma gondii remain asymptomatic or develop mild flu-like symptoms, including fever, fatigue, headache, muscle aches, and lymphadenopathy. Following primary infection, the parasite establishes latent infection that may persist for life. In immunocompromised individuals, including patients with advanced HIV infection, organ transplant recipients, and individuals receiving immunosuppressive therapy, reactivation of latent infection can cause severe disease, particularly toxoplasmic encephalitis characterized by headache, confusion, seizures, focal neurological deficits, and altered mental status. Congenital toxoplasmosis can occur when infection is acquired during pregnancy and may result in miscarriage, stillbirth, hydrocephalus, intracranial calcifications, chorioretinitis, vision impairment, developmental delay, and other severe neurological complications.

Data

FAQ & Publications

Frequently Asked Questions

What is the recommended storage condition for the Toxoplasma gondii IgG Control Serum BC110G?

The Toxoplasma gondii IgG Control Serum BC110G should be stored at 2-8°C to maintain its stability and effectiveness.

Is the Toxoplasma gondii IgG Control Serum BC110G compatible with SERION ELISA assays?

Yes, the control serum is ready-to-use and pre-diluted specifically for SERION ELISA classic and SERION ELISA antigen assays for detecting Toxoplasma gondii IgG antibodies.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC110G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Toxoplasma gondii IgG Control Serum BC110G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Aspergillus fumigatus IgG Control Serum BC132G

Echovirus IgG Control Serum BC135G

Adenovirus IgG Control Serum BC128G

Echinococcus IgG Control Serum BC107G

Human Toxoplasma gondii, rubella virus, cytomegalovirus (CMV), and herpes simplex virus type 1 and 2 (HSV-1/2) IgG Lateral flow dipstick kit 6472

Coxsackie IgG Virus Control Serum BC134G

Human Toxoplasma gondii IgG Lateral flow dipstick kit 5972

Chlamydia trachomatis IgG Control Serum BC1372G

ToRCH1/2 IgG Control Serum IC1701

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G

Brucella IgG Control Serum BC116G

Borrelia burgdorferi IgG Control Serum BC121G

Bordetella pertussis IgG Control Serum BC120G